Mark B Landon1, Lisa Mele, Catherine Y Spong, Marshall W Carpenter, Susan M Ramin, Brian Casey, Ronald J Wapner, Michael W Varner, Dwight J Rouse, John M Thorp, Anthony Sciscione, Patrick Catalano, Margaret Harper, George Saade, Steve N Caritis, Yoram Sorokin, Alan M Peaceman, Jorge E Tolosa, Garland D Anderson. 1. From the Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio; The George Washington University Biostatistics Center, Washington, DC; the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland; the Departments of Obstetrics and Gynecology at Brown University, Providence, Rhode Island; The University of Texas Health Science Center at Houston, Houston, Texas; The University of Texas Southwestern Medical Center, Dallas, Texas; Columbia University, New York, New York; University of Utah, Salt Lake City, Utah; University of Alabama at Birmingham, Birmingham, Alabama; University of North Carolina, Chapel Hill, North Carolina; Drexel University, Philadelphia, Pennsylvania; Case Western Reserve University-MetroHealth Medical Center, Cleveland, Ohio; Wake Forest University Health Sciences, Winston-Salem, North Carolina; University of Texas Medical Branch, Galveston, Texas; University of Pittsburgh, Pittsburgh, Pennsylvania; Wayne State University, Detroit, Michigan; Northwestern University, Chicago, Illinois; and Oregon Health and Science University, Portland, Oregon.
Abstract
OBJECTIVE: To examine the relationship between varying degrees of maternal hyperglycemia and pregnancy outcomes. METHODS: This was a secondary analysis of a treatment trial for mild gestational diabetes including four cohorts: 1) 473 women with untreated mild gestational diabetes; 2) 256 women with a positive 50-g screen and one abnormal oral glucose tolerance test (OGTT) value; 3) 675 women with a positive screen and no abnormal OGTT values; and 4) 437 women with a normal 50-g screen. Groups were compared by test of trend for a composite perinatal outcome (neonatal hypoglycemia, hyperbilirubinemia, elevated cord C-peptide level, and perinatal trauma or death), frequency of large for gestational age neonates, shoulder dystocia, and pregnancy-related hypertension. Three-hour OGTT levels (fasting, 1-, 2-, and 3-hour) levels were divided into categories and analyzed for their relationship to perinatal and maternal outcomes. RESULTS: There were significant trends by glycemic status among the four cohorts for the composite and all other outcomes (P<.001). Analysis for trend according to OGTT categories showed an increasing relationship between fasting and all postload levels and the various outcomes (P<.05). Fasting glucose 90 mg/dL or greater and 1 hour 165 mg/dL or greater were associated with an increased risk for the composite outcome (odds ratios and 95% confidence intervals of 2.0 [1.03–4.15] and 1.46 [1.02–2.11] to 1.52 [1.08–2.15] for the fasting and 1 hour, respectively). A 1 hour glucose 150 mg/dL or greater was associated with an increased risk for large for gestational age (odds ratios, 1.8 [1.02–3.18] to 2.35 [1.35–4.14]); however, 2- and 3-hour glucose levels did not increase the risk for the composite or large for gestational age until well beyond current gestational diabetes diagnostic thresholds. CONCLUSION: A monotonic relationship exists between increasing maternal glycemia and perinatal morbidity. Current OGTT criteria require reevaluation in determining thresholds for the diagnosis and treatment of gestational diabetes. LEVEL OF EVIDENCE: II
OBJECTIVE: To examine the relationship between varying degrees of maternal hyperglycemia and pregnancy outcomes. METHODS: This was a secondary analysis of a treatment trial for mild gestational diabetes including four cohorts: 1) 473 women with untreated mild gestational diabetes; 2) 256 women with a positive 50-g screen and one abnormal oral glucose tolerance test (OGTT) value; 3) 675 women with a positive screen and no abnormal OGTT values; and 4) 437 women with a normal 50-g screen. Groups were compared by test of trend for a composite perinatal outcome (neonatal hypoglycemia, hyperbilirubinemia, elevated cord C-peptide level, and perinatal trauma or death), frequency of large for gestational age neonates, shoulder dystocia, and pregnancy-related hypertension. Three-hour OGTT levels (fasting, 1-, 2-, and 3-hour) levels were divided into categories and analyzed for their relationship to perinatal and maternal outcomes. RESULTS: There were significant trends by glycemic status among the four cohorts for the composite and all other outcomes (P<.001). Analysis for trend according to OGTT categories showed an increasing relationship between fasting and all postload levels and the various outcomes (P<.05). Fasting glucose 90 mg/dL or greater and 1 hour 165 mg/dL or greater were associated with an increased risk for the composite outcome (odds ratios and 95% confidence intervals of 2.0 [1.03–4.15] and 1.46 [1.02–2.11] to 1.52 [1.08–2.15] for the fasting and 1 hour, respectively). A 1 hour glucose 150 mg/dL or greater was associated with an increased risk for large for gestational age (odds ratios, 1.8 [1.02–3.18] to 2.35 [1.35–4.14]); however, 2- and 3-hour glucose levels did not increase the risk for the composite or large for gestational age until well beyond current gestational diabetes diagnostic thresholds. CONCLUSION: A monotonic relationship exists between increasing maternal glycemia and perinatal morbidity. Current OGTT criteria require reevaluation in determining thresholds for the diagnosis and treatment of gestational diabetes. LEVEL OF EVIDENCE: II
Authors: Yaozhu Chen; William W Quick; Wenya Yang; Yiduo Zhang; Alan Baldwin; Jane Moran; Victoria Moore; Navita Sahai; Timothy M Dall Journal: Popul Health Manag Date: 2009-06 Impact factor: 2.459
Authors: Boyd E Metzger; Steven G Gabbe; Bengt Persson; Thomas A Buchanan; Patrick A Catalano; Peter Damm; Alan R Dyer; Alberto de Leiva; Moshe Hod; John L Kitzmiler; Lynn P Lowe; H David McIntyre; Jeremy J N Oats; Yasue Omori; Maria Ines Schmidt Journal: Diabetes Care Date: 2010-03 Impact factor: 17.152
Authors: Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson Journal: N Engl J Med Date: 2005-06-12 Impact factor: 91.245
Authors: Jodie M Dodd; Caroline A Crowther; Georgia Antoniou; Peter Baghurst; Jeffrey S Robinson Journal: Aust N Z J Obstet Gynaecol Date: 2007-08 Impact factor: 2.100
Authors: M Sermer; C D Naylor; D J Gare; A B Kenshole; J W Ritchie; D Farine; H R Cohen; K McArthur; S Holzapfel; A Biringer Journal: Am J Obstet Gynecol Date: 1995-07 Impact factor: 8.661
Authors: Lorene A Temming; Methodius G Tuuli; Molly J Stout; George A Macones; Alison G Cahill Journal: Am J Perinatol Date: 2016-02-23 Impact factor: 1.862
Authors: Brian T Nguyen; Yvonne W Cheng; Jonathan M Snowden; Tania F Esakoff; Antonio E Frias; Aaron B Caughey Journal: Am J Obstet Gynecol Date: 2012-06-29 Impact factor: 8.661
Authors: Alison M Stuebe; Mark B Landon; Yinglei Lai; Catherine Y Spong; Marshall W Carpenter; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa Journal: Am J Obstet Gynecol Date: 2012-05-02 Impact factor: 8.661
Authors: Mark B Landon; Lisa Mele; Michael W Varner; Brian M Casey; Uma M Reddy; Ronald J Wapner; Dwight J Rouse; Alan T N Tita; John M Thorp; Edward K Chien; George Saade; William Grobman; Sean C Blackwell; J Peter VanDorsten Journal: J Matern Fetal Neonatal Med Date: 2018-07-18
Authors: Alan T N Tita; Yinglei Lai; Mark B Landon; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George R Saade; Steve N Caritis; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa Journal: Am J Perinatol Date: 2017-07-19 Impact factor: 1.862